Difference between revisions of "Mapatumumab (HGS-ETR1)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Antibody medications" to "") |
m |
||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) | Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' HGS-ETR1 | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Latest revision as of 13:56, 16 December 2020
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1)
Also known as
- Code name: HGS-ETR1